Home

Samlyn Capital reported a 0% stake in Nektar Therapeutics NKTR · 0 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
0%
Last report
5.2% · filed 25/02/14
Shares held
0 sh
Class
Common Stock, $0.0001 par value
Event date
25/03/31
Filed
25/05/15

0% stake · fully exited

Stake
0%
Last report
5.2%
Since last report
−5.2pp

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Samlyn Capital's other 5% stake reports

  • Samlyn Capital

    5% stakeVinci Compass Investments

    6% stake

    Filed 08/14

  • Samlyn Capital

    5% stakePureCycle Technologies

    4.2% stake

    Filed 05/15

  • Samlyn Capital

    5% stakePureCycle Technologies

    7.2% stake

    Filed 25/11/14

  • Samlyn Capital

    5% stakePureCycle Technologies

    8.8% stake

    Filed 25/08/14

  • Samlyn Capital

    5% stakeCorvus Pharmaceuticals

    0% stake

    Filed 25/08/14